“Artificial Intelligence in Pharmaceutical Care Management for Anxiety, Depression, and Schizophrenia: A Narrative Review”, Pjmcr, vol. 4, no. 4, pp. 246–255, Oct. 2025, doi: 10.64105/vytceb34.